Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tailored Neuromodulation Intervention to Enhance Speech and Language Training in Patients With Primary Progressive Aphasia: EEG and MRI Targeted Transcranial Magnetic Stimulation

NCT06921265 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT06921265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06921265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tailored Neuromodulation Intervention to Enhance Speech and Language Training in Patients With Primary Progressive Aphasia: EEG and MRI Targeted Transcranial Magnetic Stimulation
Lead sponsor
IRCCS San Raffaele
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
May 13, 2026
Completion date
April 30, 2029
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary progressive aphasia(ppa)